DexCom, Inc.
์๊ฐ์ด์ก
$29.4B
๊ธ๋ก๋ฒ ์์
#303
์ญ๋ ์ต๊ณ ์น
$51.8B
2021-12-31
์ด ์ฑ์ฅ๋ฅ
+0%
2026๋ ์ดํ
Market Cap Context
- Larger than 17% of the 367 companies we track (globally).
- Equivalent to 0.1% of United States's GDP (2025 data).
- Just above: #302 adidas AG ($29.8B)
- Just below: #304 The Kraft Heinz Company ($29.4B)
- Best year: 2009 (+192%). Worst year: 2008 (-69%).
DexCom, Inc. Financial Breakdown (FY 2025)
Source: Yahoo Finance โ DXCM annual filings (2025) โ$4.7B revenue ยท $0.9B operating income ยท $0.8B net income
- โOperating margin: 19.6% on $4.7B in revenue.
- โR&D is 12.9% of revenue ($0.6B).
- โNet income margin: 17.9% โ $0.8B in profit.
- โFree cash flow: $1.1B (23.1% of revenue).
Cost / Operating Expenses
Total operating expenses $3.8B
Total
$3.8B
Capital Expenditures
$0.4B
This fiscal year (near-total AI infrastructure buildout)
Free Cash Flow
$1.1B
Trailing twelve months
Figures rounded from the annual SEC filing. Unaudited. For informational purposes only, not investment advice.
DexCom, Inc. ์๊ฐ
DexCom, Inc. (DXCM) is a United States-based company in the Medical Devices industry, part of the Healthcare sector. With a current market capitalization of $29.4B, it is ranked #303 among the world's largest companies. Its market cap peaked at $51.8B and reached as high as rank #199 in 2021.
DexCom, Inc. ์๊ฐ์ด์ก ์ถ์ด (2026โ2026)
DexCom, Inc. vs Sector Peers by Market Cap
DexCom, Inc. ๋น๊ต
์์ ์ถ์ด
| ์ฐ๋ | ์๊ฐ์ด์ก | ์์ | ์ ๋ ๋๋น ๋ณํ |
|---|---|---|---|
| 2026 | $29.4B | #303(โ16) | +14.8% |
| 2025 | $25.6B | #319(โ21) | -14.7% |
| 2024 | $30.0B | #298(โ70) | -37.3% |
| 2023 | $47.9B | #228(โ26) | +9.6% |
| 2022 | $43.7B | #202(โ3) | -15.6% |
| 2021 | $51.8B | #199(โ31) | +45.2% |
| 2020 | $35.7B | #230(โ40) | +69.0% |
| 2019 | $21.1B | #270(โ21) | +82.6% |
| 2018 | $11.6B | #291(โ15) | +108.7% |
| 2017 | $5.5B | #306(โ11) | -3.9% |
| 2016 | $5.8B | #295(โ24) | -27.1% |
| 2015 | $7.9B | #271(โ11) | +48.8% |
| 2014 | $5.3B | #282(โ7) | +55.5% |
| 2013 | $3.4B | #289(โ2) | +160.6% |
| 2012 | $1.3B | #291(โ2) | +46.0% |
| 2011 | $898.1M | #289(โ6) | -31.8% |
| 2010 | $1.3B | #283(โ3) | +69.1% |
| 2009 | $778.5M | #280(โ2) | +192.4% |
| 2008 | $266.3M | #282(โ8) | -68.7% |
| 2007 | $851.8M | #274(โ8) | -10.4% |
| 2006 | $951.2M | #266(โ8) | -33.9% |
| 2005 | $1.4B | #258 |
๊ธฐํ ํฌ์ค์ผ์ด ๊ธฐ์
์์ฃผ ๋ฌป๋ ์ง๋ฌธ
What is DexCom, Inc.'s market cap?
DexCom, Inc. (DXCM) has a market capitalization of $29.4B, making it the #303 largest company in the world by market cap.
What was DexCom, Inc.'s highest market cap?
DexCom, Inc.'s all-time high market cap was $51.8B, reached in 2021-12-31. Its highest rank was #199 in 2021.
What sector is DexCom, Inc. in?
DexCom, Inc. is in the Healthcare sector, specifically the Medical Devices industry. It is based in United States.
How has DexCom, Inc.'s market cap changed over time?
DexCom, Inc. has been tracked since 2026. Its market cap has grown by 0% from $29.4B in 2026 to $29.4B today.